Vida Ventures Advisors, LLC
- SEC CIK
- 0001831423
- Latest filing
- Nov 3, 2025
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Jan 5, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 7
- −1 vs. Q3 2023
- Portfolio value
- $84.0M
- +$19.4M (+30.0%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,931,818 | $31.3M | 37.3% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 2,074,787 | $27.6M | 32.9% | −145,247−6.5% | Reduced | History |
| LIANYLianBio | SPONSORED ADS | 2,282,084 | $10.2M | 12.1% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,798,163 | $5.77M | 6.9% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 2,207,772 | $5.23M | 6.2% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 2,765,314 | $3.46M | 4.1% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 225,192 | $443.6K | 0.5% | 00.0% | Unchanged | History |
Sold out since Q3 2023 (1)
Positions held at the end of Q3 2023 that are gone from this filing.